Avenue Therapeutics, Inc. (ATXI) vs Better Therapeutics, Inc. (BTTX)

Avenue Therapeutics, Inc. and Better Therapeutics, Inc. are both Biotechnology companies. Better Therapeutics, Inc. is the larger, with a market value of $850.0K against $680.0K — 1.2× the size. Across the 8 metrics below, Better Therapeutics, Inc. leads on 5 and Avenue Therapeutics, Inc. on 3.

Valuation

Metric ATXI BTTX Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 2.90 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (170.00%) 0.00% (28.84%)
Free cash flow yield (84.01%) 0.00% (23.03%)

Profitability

Metric ATXI BTTX Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (163.30%) 2,351.81% (57.72%)
Return on assets (90.50%) (162.15%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ATXI BTTX Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 89.70% 45.66% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ATXI BTTX Biotechnology median
Debt to equity 0.00 (1.44) 0.00
Current ratio 1.40 0.57 4.73
Net debt to EBITDA 0.93 0.02 0.96

Dividend

Metric ATXI BTTX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ATXI BTTX Biotechnology median
Market cap 680.00k 850.00k 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack